Shukra Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
SHUKRAPHAR
Pharmaceuticals
Share Price BSE
₹37.44
▼
-1.96 (-4.97%)
Track Shukra Pharmaceuticals share price live with TickJournal's free stock screener.
Analyze Shukra Pharmaceuticals share price history trends and compare 52-week high low
levels.
Calculate SHUKRAPHAR stock fair value using fundamental analysis and view live share price charts.
Determine Shukra Pharmaceuticals share intrinsic value and compare it with current SHUKRAPHAR share price.
Record your Shukra Pharmaceuticals trades in TickJournal's free trading journal and track your portfolio performance.
Shukra Pharmaceuticals Market Cap
₹1,843.46 Cr.
EPS (TTM)
₹0.22
Dividend Yield
0.02%
Debt to Equity
0.06
SHUKRAPHAR 52 Week High
₹64.43
Shukra Pharmaceuticals 52 Week Low
₹12.09
Operating Margin
69.00%
Profit Margin
50.00%
SHUKRAPHAR Revenue (TTM)
₹40.00
EBITDA
₹28.00
Net Income
₹20.00
Total Assets
₹87.00
Total Equity
₹63.00
Shukra Pharmaceuticals Share Price History - Stock Screener Chart
Screen SHUKRAPHAR historical share price movements with interactive charts. Analyze price trends and patterns.
Shukra Pharmaceuticals Company Profile - Fundamental Screener
Screen Shukra Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHUKRAPHAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE551C01044
Shukra Pharmaceuticals Balance Sheet Screener
Screen SHUKRAPHAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 | 17 |
| Current Assets | 65 | 56 | 53 | 16 | 16 | 15 | 11 | 8 | 7 | 6 |
| Fixed Assets | 19 | 20 | 20 | 18 | 18 | 17 | 16 | 14 | 10 | 10 |
| Liabilities | ||||||||||
| Total Liabilities | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 | 17 |
| Current Liabilities | 7 | 6 | 7 | 6 | 13 | 11 | 9 | 6 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 63 | 58 | 25 | 16 | 16 | 15 | 15 | 15 | 15 | 14 |
| Share Capital | 44 | 11 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves & Surplus | 19 | 47 | 21 | 15 | 14 | 14 | 14 | 13 | 13 | 13 |
Shukra Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Shukra Pharmaceuticals income statement and profit fundamentals.
Analyze SHUKRAPHAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shukra Pharmaceuticals share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec |
|---|---|---|---|---|---|
| Revenue | 40 | 8 | 7 | 15 | 12 |
| Expenses | 12 | 6 | 4 | 6 | 7 |
| EBITDA | 28 | 1 | 2 | 9 | 5 |
| Operating Profit % | 69.00% | -7.00% | 24.00% | 55.00% | 37.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 27 | 0 | 1 | 8 | 4 |
| Tax | 7 | -2 | 0 | 2 | 1 |
| Net Profit | 20 | 2 | 1 | 5 | 3 |
| EPS | 0.47 | 0.05 | 0.02 | 0.12 | 0.72 |
Shukra Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SHUKRAPHAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 8 | -5 | 3 | 8 | 1 | 1 | 0 | 1 | 0 | 3 |
| Investing Activities | -1 | -1 | -4 | -2 | -2 | -3 | -3 | -5 | -1 | 0 |
| Financing Activities | -5 | 12 | 5 | -7 | 2 | 2 | 2 | 4 | 0 | -1 |
| Net Cash Flow | 2 | 6 | 4 | 0 | 0 | 0 | 0 | -1 | -1 | 1 |
Shukra Pharmaceuticals Shareholding Pattern Screener
See Shukra Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Shukra Pharmaceuticals promoter holding and ownership changes for SHUKRAPHAR on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.29% | 28.69% | 9.20% | 9.43% | 9.79% | 9.19% | 9.25% | 9.41% |
| Other Holding | 39.64% | 20.24% | 39.72% | 39.50% | 39.14% | 39.73% | 39.68% | 39.51% |
| Shareholder Count | 18,231 | 20,337 | 21,441 | 25,649 | 12,974 | 14,989 | 16,321 | 17,844 |
Shukra Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Shukra Pharmaceuticals dividend history with payout and yield data.
View Shukra Pharmaceuticals dividend details including ex-dates and amounts for SHUKRAPHAR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.01 | 0.02% |
| 2024-March | ₹1.00 | 4.58% |
| 2023-March | ₹0.50 | 6.13% |
| 2022-March | ₹0.50 | 42.74% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.50 | 208.33% |
| 2018-March | ₹0.50 | 263.16% |
| 2017-March | ₹0.50 | 156.25% |
Shukra Pharmaceuticals Stock Index Membership
See which indices include Shukra Pharmaceuticals stock.
Check SHUKRAPHAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shukra Pharmaceuticals Market Events Screener - Corporate Actions
Get Shukra Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Shukra Pharmaceuticals stock events that may affect SHUKRAPHAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.01 /share | 126.55% | ||
| Dividend | ₹ 0.50 /share | 253.33% | ||
| Dividend | ₹ 1.00 /share | -40.51% | ||
| Annual General Meeting | NA | 5.63% | ||
| Annual General Meeting | NA | 34.10% | ||
| Dividend | ₹ 0.50 /share | 76.74% | ||
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | -7.11% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.17% |
| 2025-11-01 | 2025-11-01 | Extraordinary General Meeting | NA | 19.04% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -9.76% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -5.08% |
| 2025-03-21 | 2025-01-29 | Split | 1:10 | 0.00% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.64% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.35% |
| 2024-08-23 | 2024-08-23 | Extraordinary General Meeting | NA | -31.85% |
Shukra Pharmaceuticals Competitors Screener - Peer Comparison
Screen SHUKRAPHAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 408,007 | 37.20 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 163,250 | 66.07 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 144,229 | 64.43 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 109,566 | 23.71 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 105,948 | 19.16 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 101,478 | 21.52 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,613 | 18.12 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 86,000 | 47.17 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 68,802 | 19.14 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 65,528 | 26.80 | 13,458 | 3.70% | 2,216 | 40.44 |
Shukra Pharmaceuticals Company Announcements - News Screener
Screen SHUKRAPHAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-05 | Newspaper Publication Of Standalone And Consolidated Un-Audited Financial Results For Quarter And Nine Month Ended 31St December 2025 | View |
| 2026-02-04 | Unaudited Financial Results For The Quarter Ended December 2025 | View |
| 2026-02-04 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday February 04 2026 | View |
| 2026-01-30 | Update on board meeting | View |
| 2026-01-30 | Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December 2025 Along With The Auditors Limited Review Report. | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2026-01-28 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Today | View |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-05 | Voting Result Along With Scrutinizer Report Of Postal Ballot | View |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-12-30 | Reconstitution Of Committees Of The Company. | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-12-30 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30 2025. | View |
| 2025-12-23 | Closure of Trading Window | View |
| 2025-12-22 | Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations Working In The Government Market Of Gujarat For Our Laparoscopic Sets And Accessories. | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-12-03 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-29 | Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who Has Attained Age Of 75 Years On September 22 2025 Subject To Approval Of Shareholders. | View |